SELLAS Life Sciences Group (SLS) Change in Account Payables: 2011-2024
Historic Change in Account Payables for SELLAS Life Sciences Group (SLS) over the last 7 years, with Sep 2024 value amounting to -$1.8 million.
- SELLAS Life Sciences Group's Change in Account Payables fell 391.75% to -$1.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $297,000, marking a year-over-year decrease of 86.58%. This contributed to the annual value of -$2.1 million for FY2024, which is 192.96% down from last year.
- As of Q3 2024, SELLAS Life Sciences Group's Change in Account Payables stood at -$1.8 million, which was down 66.95% from -$1.1 million recorded in Q2 2024.
- SELLAS Life Sciences Group's 5-year Change in Account Payables high stood at $1.8 million for Q1 2024, and its period low was -$1.8 million during Q3 2024.
- Its 3-year average for Change in Account Payables is $226,636, with a median of $606,000 in 2023.
- As far as peak fluctuations go, SELLAS Life Sciences Group's Change in Account Payables plummeted by 1,897.22% in 2020, and later surged by 735.92% in 2024.
- Quarterly analysis of 5 years shows SELLAS Life Sciences Group's Change in Account Payables stood at $1.3 million in 2020, then crashed by 131.16% to -$401,000 in 2021, then soared by 406.73% to $1.2 million in 2022, then rose by 7.15% to $1.3 million in 2023, then plummeted by 391.75% to -$1.8 million in 2024.
- Its Change in Account Payables stands at -$1.8 million for Q3 2024, versus -$1.1 million for Q2 2024 and $1.8 million for Q1 2024.